Diabetes may not affect outcomes in hepatocellular carcinoma after radio-frequency ablation

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 551-557

  Chen, Wei Ting ^a   Macatula, Therese Capalongan ^a,b   Lin, Chen Chun ^a   Lin, Chun Jung ^a   Lin, Shi Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Diabetes; Hepatocellular carcinoma; Intra hepatic tumor recurrence; Radiofrequency ablation; Survival

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DIABETES COMPLICATIONS; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79958127529     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bruix J, Sherman M: AASLD Practice Guideline. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
2. Kingston ME, Ali MA, Atiyeh M, et al: Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984; 87:688-694. (Pubitemid 14061425)
3. Adami HO, Chow WH, Nyren O, et al: Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88:1472-1477. (Pubitemid 26340049)
4. LaVecchia C,NegriE, Decarli A, et al: Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73:204-207. (Pubitemid 27448819)
5. Tazawa J, Maeda M, Nakagawa M, et al: Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci 2002; 47:710-715. (Pubitemid 34286861)
6. Hassan MM, Hwang LY, Hatten CJ, et al: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36:1206-1213. (Pubitemid 35253437)
7. Yanaga K, Matsumata T, Hayashi H, et al: Effect of diabetes mellitus on hepatic resection. Arch Surg 1993; 128:445-448. (Pubitemid 23115389)
8. Shimada M, Hasegawa H, Gion T, et al: Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy. Hepato-gastroenterology 1999; 46:2469-2475. (Pubitemid 29454124)
9. Poon RT, Fan ST, Wong J: Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? Am J Gastroenterol 2002; 97:1480-1488.
10. Ikeda Y, Shimada M, Hasegawa H, et al: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27:1567-1571. (Pubitemid 28264680)
11. Shimada M, Hasegawa H, Gion T, et al: Risk factors of the recurrence of hepatocellular carcinoma originating from residual cancer cells after hepatectomy. Hepato-gastroenterology 1999; 46:2469-2475. (Pubitemid 29454124)
12. Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H: Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. J Gastroenterol Hepatol 2008; 23:1739-1746.
13. Toyoda H, Kumada T, Nakano S, et al: Impact of diabetes mellitus on the prognosis of patients hepatocellular carcinoma. Cancer 2001; 91:957-963.
14. Huo TI, Wu JC, Lee PC, et al: Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol 2004; 99:1479-1487.
15. Goldberg N, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, Dupuy DE, Gervais D, Gillams AR, Kane AR, Lee FT, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG: Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2005; 16:765-778. (Pubitemid 40847897)
16. Lin SM, Lin CC, Chen WT, Chen YC, Hsu CW: Radiofrequency ablation for hepatocellular carcinoma: A prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007; 18:1118-1125.
17. Lin SM, Lin CJ, Chung HJ, Hsu CW, Peng CY: Power roll-off during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma. Am J Roentgenol AJR 2003; 180:151-157.
18. Ikeda Y, Shimada M, Hasegawa H, et al: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27:1567-1571. (Pubitemid 28264680)
19. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population-based case-control study. Gut 2005; 54:533-539. (Pubitemid 40403031)
20. Komura T, Mizukoshi E, Kita Y, Sakurai M, Takata Y, Arai K, Yamashita T, Ohta T, Shimizu K, Nakamoto Y, Honda M, Takamura T, Kaneko S: Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol 2007; 102:1939-1946. (Pubitemid 47301526)
21. Poon RT, Fan ST, Lo CM, Liu CL, Wong J: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229:216-222. (Pubitemid 30191795)
22. Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A and El-Malah A: Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 2007; 37:658-672. (Pubitemid 47617785)
23. Harrison LE, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho KC, Contractor D, Korogodsky M: Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197:759-764.
24. Michielsen PP, Francque SM, van Dongen JL: Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 2005; 3:27-44.
25. Caselmann WH: Pathogenesis of hepatocellular carcinoma. Digestion 1998; 59:60-63.
26. Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD: Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol 2003; 15:1203-1208.
27. Lin SM, Lin CJ, Hsu CW, Tai DI, Sheen IS, Lin DY, Liaw YF: Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004; 100:376-382.
28. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, for the REVEAL-HBV Study Group: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295:65-73. (Pubitemid 43042691)
29. Kim WR, Flamm SL, Di Bisceglie AM, Bodenhaimer Jr HC, on behalf of the Public Policy Committee of the American Association for the Study of the Liver Disease: Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatololgy 2008; 47:1363-1370.
30. Hui JM, Sud A, Farrell GC, et al: Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125:1695-1704. (Pubitemid 37500434)
31. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R: High prevalence of glucose abnormalities in patients with hepatitis C virus infection: A multivariate analysis considering the liver injury. Diabetes Care 2004; 27:1171-1175. (Pubitemid 38579785)
32. Camma C, Bruno S, Di Marco V, Di Bona D, Rumi M, Vinci M, et al: Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 2006; 43:64-71. (Pubitemid 43738959)
33. Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M: Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 2008; 6:459-464. (Pubitemid 351443115)